152 related articles for article (PubMed ID: 19293637)
1. Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor.
Lee KH; Kim JR
Exp Mol Med; 2009 Mar; 41(3):180-8. PubMed ID: 19293637
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells.
Lee KH; Kim SW; Kim JR
J Exp Clin Cancer Res; 2009 Jun; 28(1):73. PubMed ID: 19497102
[TBL] [Abstract][Full Text] [Related]
3. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
Lee KH; Hyun MS; Kim JR
Clin Exp Metastasis; 2003; 20(6):499-505. PubMed ID: 14598883
[TBL] [Abstract][Full Text] [Related]
4. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.
Lee KH; Choi EY; Kim MK; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
Exp Mol Med; 2006 Feb; 38(1):27-35. PubMed ID: 16520550
[TBL] [Abstract][Full Text] [Related]
5. Cellular mechanisms of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MAPK signaling in hepatocellular carcinoma.
Lee KH; Choi EY; Hyun MS; Eun JR; Jang BI; Kim TN; Lee HJ; Lee DS; Yun SS; Kim HJ; Kim JH; Kim JR
Tumori; 2008; 94(4):523-30. PubMed ID: 18822689
[TBL] [Abstract][Full Text] [Related]
6. Nicotine stimulates urokinase-type plasminogen activator receptor expression and cell invasiveness through mitogen-activated protein kinase and reactive oxygen species signaling in ECV304 endothelial cells.
Khoi PN; Park JS; Kim NH; Jung YD
Toxicol Appl Pharmacol; 2012 Mar; 259(2):248-56. PubMed ID: 22261521
[TBL] [Abstract][Full Text] [Related]
7. Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.
Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Lee HJ; Eun JY; Kim HG; Yoon SS; Lee DS; Kim JH; Kim JR
Clin Exp Metastasis; 2008; 25(1):89-96. PubMed ID: 17992475
[TBL] [Abstract][Full Text] [Related]
8. IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment.
Lee KH; Choi EY; Koh SA; Kim MK; Jang BI; Kim SW; Kim JR
Oncol Rep; 2014 May; 31(5):2123-30. PubMed ID: 24626561
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells.
Tacchini L; Dansi P; Matteucci E; Desiderio MA
Carcinogenesis; 2001 Sep; 22(9):1363-71. PubMed ID: 11532856
[TBL] [Abstract][Full Text] [Related]
10. Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells.
Han Q; Leng J; Bian D; Mahanivong C; Carpenter KA; Pan ZK; Han J; Huang S
J Biol Chem; 2002 Dec; 277(50):48379-85. PubMed ID: 12377770
[TBL] [Abstract][Full Text] [Related]
11. P38 MAPK pathway is involved in the urokinase plasminogen activator expression in human gastric SNU-638 cells.
Shin BA; Yoo HG; Kim HS; Kim MH; Hwang YS; Chay KO; Lee KY; Ahn BW; Jung YD
Oncol Rep; 2003; 10(5):1467-71. PubMed ID: 12883725
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells.
Wojta J; Nakamura T; Fabry A; Hufnagl P; Beckmann R; McGrath K; Binder BR
Blood; 1994 Jul; 84(1):151-7. PubMed ID: 7517205
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species stimulated human hepatoma cell proliferation via cross-talk between PI3-K/PKB and JNK signaling pathways.
Liu SL; Lin X; Shi DY; Cheng J; Wu CQ; Zhang YD
Arch Biochem Biophys; 2002 Oct; 406(2):173-82. PubMed ID: 12361705
[TBL] [Abstract][Full Text] [Related]
14. Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cells.
Nishimura K; Matsumiya K; Miura H; Tsujimura A; Nonomura N; Matsumoto K; Nakamura T; Okuyama A
Int J Androl; 2003 Jun; 26(3):175-9. PubMed ID: 12755996
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
16. Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells.
Usatyuk PV; Vepa S; Watkins T; He D; Parinandi NL; Natarajan V
Antioxid Redox Signal; 2003 Dec; 5(6):723-30. PubMed ID: 14588145
[TBL] [Abstract][Full Text] [Related]
17. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.
Huang S; New L; Pan Z; Han J; Nemerow GR
J Biol Chem; 2000 Apr; 275(16):12266-72. PubMed ID: 10766865
[TBL] [Abstract][Full Text] [Related]
18. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
[TBL] [Abstract][Full Text] [Related]
19. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion.
Montero L; Nagamine Y
Cancer Res; 1999 Oct; 59(20):5286-93. PubMed ID: 10537311
[TBL] [Abstract][Full Text] [Related]
20. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]